7 results
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... risks, and therapy should ... #pharmacology #pharmacotherapy ... #endocrinology ... #treatment
Diabetic Peripheral Neuropathy - Pharmacotherapy

Peripheral neuropathy is a common microvascular complication of diabetes. In clinic patients
Diabetic Peripheral ... complication of diabetes ... clinic patients should ... pregabalin as treatment ... #Pharmacology #
Pharmacologic treatment of hyperglycemia in adults with type 2 diabetes

#Diabetes #Management #Algorithm #endocrinology #pharmacology #medications
Pharmacologic treatment ... adults with type 2 diabetes ... #Diabetes #Management ... #Algorithm #endocrinology ... #pharmacology #
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Management of Diabetes ... initiation of treatment ... recommends, metformin should ... and CKD should ... evidence-based pharmacologic
Pituitary Mass Effects - Pathogenesis and Clinical Findings
 • Pituitary turnors are almost always a benign
adenomas that require treatment ... not always) the anterior ... Hyperprolactinemia • Diabetes ... #SideEffects #endocrinology
Optimal glycemic control is fundamental to the management of diabetes.

A1C% measurement approximately every 3 months determines
of A1C testing should ... situation, the treatment ... , an A1C ≤7.0% should ... #management #endocrinology ... #treatment #table
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
Patients should ... been shown non-inferior ... #semaglutide #Diabetes ... #Pharmacology # ... Endocrinology